{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:29:52Z","timestamp":1761290992606},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10637-014-0157-7","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T08:07:15Z","timestamp":1411027635000},"page":"109-118","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study"],"prefix":"10.1007","volume":"33","author":[{"given":"Joal D.","family":"Beane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla F.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot B.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Pandalai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Abi-Jaoudeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Beresnev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Shutack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole C.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzhak","family":"Avital","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Rudloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"key":"157_CR1","unstructured":"Cancer Facts and Figures (2013) American Cancer Society, Atlanta, GA"},{"issue":"1","key":"157_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1072-7515(99)00075-7","volume":"189","author":"SF Sener","year":"1999","unstructured":"Sener SF, Fremgen A, Menck HR, Winchester DP (1999) Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985\u20131995, using the National Cancer Database. J Am Coll Surg 189(1):1\u20137","journal-title":"J Am Coll Surg"},{"issue":"9","key":"157_CR3","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R","volume":"76","author":"JE Niederhuber","year":"1995","unstructured":"Niederhuber JE, Brennan MF, Menck HR (1995) The National Cancer Data Base report on pancreatic cancer. Cancer 76(9):1671\u20131677","journal-title":"Cancer"},{"issue":"3","key":"157_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00000658-199603000-00006","volume":"223","author":"RH Janes Jr","year":"1996","unstructured":"Janes RH Jr, Niederhuber JE, Chmiel JS, Winchester DP, Ocwieja KC, Karnell JH, Clive RE, Menck HR (1996) National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer. Ann Surg 223(3):261\u2013272","journal-title":"Ann Surg"},{"issue":"11","key":"157_CR5","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1245\/s10434-010-1285-8","volume":"17","author":"DB Evans","year":"2010","unstructured":"Evans DB, Erickson BA, Ritch P (2010) Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. Ann Surg Oncol 17(11):2803\u20132805. doi:10.1245\/s10434-010-1285-8","journal-title":"Ann Surg Oncol"},{"key":"157_CR6","volume-title":"Pancreatic cancer and tumor microenvironment","author":"CJ Whatcott","year":"2012","unstructured":"Whatcott CJ, Posner RG, Von Hoff DD, Han H (2012) Desmoplasia and chemoresistance in pancreatic cancer. In: Grippo PJ, Munshi HG (eds) Pancreatic cancer and tumor microenvironment. Transworld Research Network, Trivandrum"},{"issue":"4","key":"157_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/jso.23392","volume":"108","author":"BA Boone","year":"2013","unstructured":"Boone BA, Steve J, Krasinskas AM, Zureikat AH, Lembersky BC, Gibson MK, Stoller RG, Zeh HJ, Bahary N (2013) Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer. J Surg Oncol 108(4):236\u2013241. doi:10.1002\/jso.23392","journal-title":"J Surg Oncol"},{"issue":"21","key":"157_CR8","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1200\/JCO.2007.15.8634","volume":"26","author":"DB Evans","year":"2008","unstructured":"Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA (2008) Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol Off J Am Soc Clin Oncol 26(21):3496\u20133502. doi:10.1200\/JCO.2007.15.8634","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"157_CR9","doi-asserted-by":"publisher","first-page":"e40847","DOI":"10.1371\/journal.pone.0040847","volume":"7","author":"F Liu","year":"2012","unstructured":"Liu F, Tang Y, Sun J, Yuan Z, Li S, Sheng J, Ren H, Hao J (2012) Regional intra-arterial vs. systemic chemotherapy for advanced pancreatic cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE 7(7):e40847","journal-title":"PLoS ONE"},{"issue":"2","key":"157_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/1097-0142(20000715)89:2<303::AID-CNCR15>3.0.CO;2-1","volume":"89","author":"H Homma","year":"2000","unstructured":"Homma H, Doi T, Mezawa S, Takada K, Kukitsu T, Oku T, Akiyama T, Kusakabe T, Miyanishi K, Niitsu Y (2000) A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization. Cancer 89(2):303\u2013313","journal-title":"Cancer"},{"issue":"6C","key":"157_CR11","first-page":"4407","volume":"25","author":"KR Aigner","year":"2005","unstructured":"Aigner KR, Gailhofer S (2005) Celiac axis infusion and microembolization for advanced stage III\/IV pancreatic cancer\u2014a phase II study on 265 cases. Anticancer Res 25(6C):4407\u20134412","journal-title":"Anticancer Res"},{"issue":"6","key":"157_CR12","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris 3rd","year":"1997","unstructured":"Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol Off J Am Soc Clin Oncol 15(6):2403\u20132413","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"18","key":"157_CR13","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1200\/JCO.2003.09.140","volume":"21","author":"M Tempero","year":"2003","unstructured":"Tempero M, Plunkett W, Ruiz Van Haperen V, Hainsworth J, Hochster H, Lenzi R, Abbruzzese J (2003) Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. J Clin Oncol Off J Am Soc Clin Oncol 21(18):3402\u20133408. doi:10.1200\/JCO.2003.09.140","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"157_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1745-6215-12-129","volume":"12","author":"JL Davis","year":"2011","unstructured":"Davis JL, Pandalai P, Ripley RT, Langan RC, Steinberg SM, Walker M, Toomey MA, Levy E, Avital I (2011) Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial. Trials 12:129. doi:10.1186\/1745-6215-12-129","journal-title":"Trials"},{"issue":"9","key":"157_CR15","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2165\/00003088-200544090-00005","volume":"44","author":"AI Shamseddine","year":"2005","unstructured":"Shamseddine AI, Khalifeh MJ, Mourad FH, Chehal AA, Al-Kutoubi A, Abbas J, Habbal MZ, Malaeb LA, Bikhazi AB (2005) Comparative pharmacokinetics and metabolic pathway of gemcitabine during intravenous and intra-arterial delivery in unresectable pancreatic cancer patients. Clin Pharmacokinet 44(9):957\u2013967. doi:10.2165\/00003088-200544090-00005","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"157_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205\u2013216","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"157_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35(3):421\u2013430","journal-title":"J Hepatol"},{"issue":"6","key":"157_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.surg.2014.02.001","volume":"155","author":"M Bockhorn","year":"2014","unstructured":"Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, Asbun HJ, Bassi C, Buchler M, Charnley RM, Conlon K, Cruz LF, Dervenis C, Fingerhutt A, Friess H, Gouma DJ, Hartwig W, Lillemoe KD, Montorsi M, Neoptolemos JP, Shrikhande SV, Takaori K, Traverso W, Vashist YK, Vollmer C, Yeo CJ, Izbicki JR, International Study Group of Pancreatic S (2014) Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 155(6):977\u2013988. doi:10.1016\/j.surg.2014.02.001","journal-title":"Surgery"},{"issue":"1","key":"157_CR19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0016-5085(81)90211-0","volume":"80","author":"N Shapiro","year":"1981","unstructured":"Shapiro N, Brandt L, Sprayregan S, Mitsudo S, Glotzer P (1981) Duodenal infarction after therapeutic Gelfoam embolization of a bleeding duodenal ulcer. Gastroenterology 80(1):176\u2013180","journal-title":"Gastroenterology"},{"issue":"14","key":"157_CR20","first-page":"4417","volume":"50","author":"LW Hertel","year":"1990","unstructured":"Hertel LW, Boder GB, Kroin JS, Rinzel SM, Poore GA, Todd GC, Grindey GB (1990) Evaluation of the antitumor activity of gemcitabine (2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine). Cancer Res 50(14):4417\u20134422","journal-title":"Cancer Res"},{"issue":"22","key":"157_CR21","first-page":"6110","volume":"51","author":"P Huang","year":"1991","unstructured":"Huang P, Chubb S, Hertel LW, Grindey GB, Plunkett W (1991) Action of 2\u2032,2\u2032-difluorodeoxycytidine on DNA synthesis. Cancer Res 51(22):6110\u20136117","journal-title":"Cancer Res"},{"issue":"3","key":"157_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1634\/theoncologist.2007-0215","volume":"13","author":"SA Veltkamp","year":"2008","unstructured":"Veltkamp SA, Beijnen JH, Schellens JHM (2008) Prolonged versus standard gemcitabine infusion: translation of molecular pharmacology to new treatment strategy. Oncologist 13(3):261\u2013276. doi:10.1634\/theoncologist.2007-0215","journal-title":"Oncologist"},{"issue":"3","key":"157_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/bjc.1996.382","volume":"74","author":"H Anderson","year":"1996","unstructured":"Anderson H, Thatcher N, Walling J, Hansen H (1996) A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer. Br J Cancer 74(3):460\u2013462","journal-title":"Br J Cancer"},{"issue":"2","key":"157_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/A:1005817024382","volume":"15","author":"CF Pollera","year":"1997","unstructured":"Pollera CF, Ceribelli A, Crecco M, Oliva C, Calabresi F (1997) Prolonged infusion gemcitabine: a clinical phase I study at low- (300 mg\/m2) and high-dose (875 mg\/m2) levels. Investig New Drugs 15(2):115\u2013121","journal-title":"Investig New Drugs"},{"issue":"3","key":"157_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1200\/JCO.20.3.674","volume":"20","author":"DA Rizzieri","year":"2002","unstructured":"Rizzieri DA, Bass AJ, Rosner GL, Gockerman JP, DeCastro CM, Petros WP, Adams DJ, Laughlin MJ, Davis P, Foster T, Jacobson R, Hurwitz H, Moore JO (2002) Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia. J Clin Oncol Off J Am Soc Clin Oncol 20(3):674\u2013679","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"157_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1200\/JCO.20.3.665","volume":"20","author":"V Gandhi","year":"2002","unstructured":"Gandhi V, Plunkett W, Du M, Ayres M, Estey EH (2002) Prolonged infusion of gemcitabine: clinical and pharmacodynamic studies during a phase I trial in relapsed acute myelogenous leukemia. J Clin Oncol Off J Am Soc Clin Oncol 20(3):665\u2013673","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"157_CR27","first-page":"89","volume":"116","author":"Z Ji","year":"2003","unstructured":"Ji Z, Wang Y, Chen X, Wu T (2003) Peripancreatic artery ligation and artery infusion chemotherapy for advanced pancreatic carcinoma. Chin Med J 116(1):89\u201392","journal-title":"Chin Med J"},{"key":"157_CR28","first-page":"479","volume":"21","author":"HQ Liu","year":"2008","unstructured":"Liu HQ, Li Y, Huang RW, Huang XP (2008) Clinical observation of transarterial infusion chemotherapy of GP for treatment of advanced pancreatic carcinoma. J Basic Clin Oncol 21:479\u2013481","journal-title":"J Basic Clin Oncol"},{"issue":"5","key":"157_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10330-007-0086-4","volume":"6","author":"G Hong","year":"2007","unstructured":"Hong G, Zhou J, Luo J, Xu L, Chen Y, Jiang R (2007) A clinical study on continuous transarterial infusion chemotherapy and systemic venous chemotherapy with gemcitabine and 5-fluorouracil in treating patients with advanced pancreatic carcinoma. Chin German J Clin Oncol 6(5):457\u2013460. doi:10.1007\/s10330-007-0086-4","journal-title":"Chin German J Clin Oncol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-014-0157-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-014-0157-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-014-0157-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-014-0157-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:57:38Z","timestamp":1678510658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-014-0157-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["157"],"URL":"https:\/\/doi.org\/10.1007\/s10637-014-0157-7","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]},"assertion":[{"value":"7 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}